NCT03909529 - Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2019

Primary Completion Date

April 19, 2019

Study Completion Date

April 30, 2019

Conditions

Drug Drug Interaction

Interventions

DRUG

Digoxin 250 MCG Oral Tablet

The intervention is for study of drug drug interaction of digoxin when administered with spironolactone oral suspension

DRUG

Spironolactone 25 mg/ 5 mL S/F Suspension

The intervention is for study of drug drug interaction of digoxin when administered with spironolactone oral suspension

Trial Locations (1)

ClinSync Clinical Research Pvt. Ltd., Hyderabad